Endocrine Disorders
Recordati AG supports clinical research in endocrinology with a focus on conditions that affect hormonal regulation and metabolic balance, particularly Cushing’s disease.
- Hormone-secreting pituitary disorders
- Paediatric and adolescent endocrine care
- Adrenocorticotropic hormone-related disease management
Its studies include therapeutic interest in treatments for Cushing’s disease across younger patient populations and in settings where endocrine control is central to symptom management.
Post-Bariatric Hypoglycaemia
The sponsor funds research on post-bariatric hypoglycaemia, addressing glucose instability that can occur after bariatric surgery and affect daily metabolic control.
- Reactive hypoglycaemia
- Postprandial glucose regulation
- Metabolic complications after weight-loss surgery
Clinical interest in this area centres on therapies intended to reduce glucose excursions and improve symptom control in adults living with persistent hypoglycaemic episodes.
Paediatric Endocrine Pharmacology
Recordati AG also investigates endocrine therapies in children and adolescents, with attention to age-specific treatment needs in Cushing’s disease and related hormonal disorders.
- Paediatric pharmacokinetics
- Age-appropriate endocrine treatment
- Adolescent hormone disorder management
This research area reflects interest in how endocrine medicines are handled in younger patients and how treatment options may be adapted for developmental stages.
Subcutaneous Therapeutics
The sponsor’s trial portfolio includes work on subcutaneous administration of endocrine medicines, with attention to absorption, delivery consistency, and patient-use considerations.
- Drug absorption
- Injection-site comparison
- Device-based delivery
Research in this domain supports the clinical development of injectable therapies used in endocrine and metabolic disorders.
